Effects of Anti-VEGF Targeted Drugs on Patients' Blood Pressure and Endothelial Function

NCT04962438 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-07-15

No results posted yet for this study

Summary

Explore the effects of anti-VEGF targeted drugs on blood pressure and endothelial function in cancer patients.

Conditions

  • Cardiac Toxicity
  • VEGF
  • Endothelial Dysfunction

Interventions

DRUG

Anti-VEGF

Anti-tumor drugs targeting the vascular endothelial growth factor (VEGF) signaling pathway

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-05
Primary Completion
2021-12-01
Completion
2021-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04962438 on ClinicalTrials.gov